Dream Akose

Marsoni

M251S

$65.00

Get it in 3 business days with 1 day shipping. Friday, May 29

Dream AkoseIfa medicine used to rid user of bad dreams. Brings blessings and protection at night. Open Roads. Safe for children and pregnant woman. First time users must 3 consecutive washes required. The rest can be used based on need. Type: Black soap Quantity: 3 or 7 Doses

Easy Shipping

Quick Dispatch:

Your Dream Akose orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Dream Akose ships.

Need Help?
Questions about Dream Akose, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Dream Akose in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Biotene Oral Rinse mouthwash was the answer for a pre-rinse mouth wash, even before bed to leave my mouth sweet and moist. Instead of having to drink something or taste something - - - so I won't eat something before bed. It's been a miracle answer for pre-bed and dry mouth during a sleep period and wakening dryer than I want to be. I used to use Biotene "dry mouth spray", now I don't have to because the Oral mouthwash is my go to! enough said!!

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on May 30, 2026

Verified Purchase

Jamie Ann

New York, US

★★★★★ 5

Great for chemo

Flavor Name: Mint, Size: 33.8 Fl Oz (Pack of 1)

I ended up ordering this due to hearing mouth sores occurring during chemo. Using it twice a day to keep from getting the sours and it’s working great.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on May 17, 2026